§ 1523. Definitions

Statutory text

In this subchapter:

Administrator

The term “Administrator” means the Administrator appointed by the Director under section 1531(c) of this title.

Advisory Commission

The term “Advisory Commission” means the Advisory Commission established under section 1541 1 of this title.

Community

The term “community” shall have the meaning provided that term by the Administrator, in consultation with the Advisory Commission.

Director

The term “Director” means the Director of the Office of National Drug Control Policy.

Eligible coalition

The term “eligible coalition” means a coalition that meets the applicable criteria under section 1532(a) of this title.

Grant recipient

The term “grant recipient” means the recipient of a grant award under section 1532 of this title.

Nonprofit organization

The term “nonprofit organization” means an organization described under section 501(c)(3) of title 26 that is exempt from taxation under section 501(a) of title 26.

Program

The term “Program” means the program established under section 1531(a) of this title.

Substance use and misuse

The term “substance use and misuse” means—

the illegal use or misuse of drugs, including substances for which a listing is effect 2 under any of schedules I through V under section 812 of this title;

the misuse of inhalants or over-the-counter drugs; or

the use of alcohol, tobacco, or other related product as such use is prohibited by State or local law.

Youth

The term “youth” shall have the meaning provided that term by the Administrator, in consultation with the Advisory Commission.

Footnotes

1 See References in Text note below.
2 So in original.

Legislative history

Reconstructed from this section’s Code source credit and amendment notes, resolved against the local Statutes at Large. Editorial notes are evidence, not the law that made the change.

1997
Anti-Drug Abuse Act of 1988
Pub. L. 100–690 title I § 1023 · 102 Stat. 4181
Enacted · 21 U.S.C. § 1523
Pub. L. 100–690, title I, § 1023, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 225
Source evidence
Code source credit
Pub. L. 100–690, title I, § 1023, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 225
2018
Substance Abuse Prevention Act of 2018
Pub. L. 115–271 § 8203(b)(2) · 132 Stat. 3894
1. Amended · 21 U.S.C. § 1523(9)
  Pub. L. 115–271, § 8203(b)(2), as amended by Pub. L. 116–74, § 2(c)(1)(A)(ii)(II)
2. Added · 21 U.S.C. § 1523(9)
  Pub. L. 115–271, § 8203(b)(2), as added par. (9)
3. Struck · 21 U.S.C. § 1523(9)
  Pub. L. 115–271, § 8203(b)(2), as struck out former par. (9) which defined “substance abuse”
Source evidence
Code amendment note
Par. (9). Pub. L. 115–271, § 8203(b)(2), as amended by Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), added par. (9) and struck out former par. (9) which defined “substance abuse”.
Enacted provision · exact public law section
(2) in section 1023 (21 U.S.C. 1523), by striking paragraph (9) and inserting the following: “(9) Substance use and misuse.— The term ‘substance use and misuse’ means— “(A) the illegal use or misuse of drugs, including substances for which a listing is effect under any of schedules I through V under section 202 of the Controlled Substances Act (21 U.S.C. 812); “(B) the misuse of inhalants or over-the-counter drugs; or “(C) the use of alcohol, tobacco, or other related product as such use is prohibited by State or local law.” ;
Effective date note
Amendment by Pub. L. 116–74 effective as if included in the enactment of subtitle K of title VIII of Pub. L. 115–271, see section 2(c)(2) of Pub. L. 116–74, set out as a note under section 1522 of this title.
2019
ONDCP Technical Corrections Act of 2019
Pub. L. 116–74 § 2(c)(1)(A)(ii)(II) · 133 Stat. 1155
Changed · 21 U.S.C. § 1523(9)
Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), made technical amendment to directory language of Pub. L. 115–271, § 8203(b)(2). See 2018 Amendment note below
Source evidence
Code amendment note
Par. (9). Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), made technical amendment to directory language of Pub. L. 115–271, § 8203(b)(2). See 2018 Amendment note below.
Enacted provision · exact public law section
(II) in the matter preceding paragraph (1), by striking “National Narcotics Leadership Act of 1988” and inserting “Anti-Drug Abuse Act of 1988”; and
Effective date note
Amendment by Pub. L. 116–74 effective as if included in the enactment of subtitle K of title VIII of Pub. L. 115–271, see section 2(c)(2) of Pub. L. 116–74, set out as a note under section 1522 of this title.

4 of 5 references resolved to an enrolled provision · 1 partial

Editorial Notes

References in Text

Section 1541 of this title, referred to in par. (2), was repealed by Pub. L. 115–271, title VIII, § 8203(b)(5), Oct. 24, 2018, 132 Stat. 4112.

Amendments2018–2019 · 2 rounds

2019

Par. (9). Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), made technical amendment to directory language of Pub. L. 115–271, § 8203(b)(2). See 2018 Amendment note below.

2018

Par. (9). Pub. L. 115–271, § 8203(b)(2), as amended by Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), added par. (9) and struck out former par. (9) which defined “substance abuse”.

Statutory Notes and Related Subsidiaries

Effective Date of 2019 Amendment

Amendment by Pub. L. 116–74 effective as if included in the enactment of subtitle K of title VIII of Pub. L. 115–271, see section 2(c)(2) of Pub. L. 116–74, set out as a note under section 1522 of this title.

Credits

1997–2019 · 3 acts

1997Pub. L. 100–690, title I, § 1023, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 225
2018amended Pub. L. 115–271, title VIII, § 8203(b)(2), Oct. 24, 2018, 132 Stat. 4111
2019Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), Nov. 27, 2019, 133 Stat. 1157.

Show as published

(Pub. L. 100–690, title I, § 1023, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 225; amended Pub. L. 115–271, title VIII, § 8203(b)(2), Oct. 24, 2018, 132 Stat. 4111; Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), Nov. 27, 2019, 133 Stat. 1157.)